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Background/aim: Hydroxychloroquine (HCQ) is an antimalarial that is widely used in the management of rheumatoid arthritis and
other autoimmune diseases. In this study, we aimed to examine the vascular effects of HCQ on rat aorta (RA).
Materials and methods: The RA rings were suspended in isolated organ baths and tension was recorded isometrically. HCQ-induced
relaxations were tested in the presence of the nitric oxide synthase inhibitor, nitro-L-arginine methyl ester (L-NAME, 100 mM); the
cyclooxygenase enzyme inhibitor, indomethacin (10 mM); the calcium (Ca2+) ion channel blocker, nilvadipine (10 μM); and the K+ ion
channel inhibitors, tetraethylammonium (1 mM), glibenclamide (10 mM), 4-aminopyridine (1 mM), and barium chloride (30 mM).
The effect of HCQ on Ca2+ channels was examined using Ca2+-free Krebs solution, and adding calcium chloride (CaCl2, 10-5– 10-2 M)
cumulatively to baths incubated with HCQ.
Results: Removing the endothelium resulted in less relaxation of RA rings compared to endothelium-intact rings (p < 0.05). The effect
of endothelium was supported by using L-NAME where HCQ produced-vasorelaxation was decreased (p < 0.05). The contraction of
vascular rings was inhibited to a significant degree following the addition of CaCl2, PE, or KCl on HCQ-incubated RA rings (p < 0.05).
The incubation of the RA rings with the Ca2+ channel blocker, the K+ channel blockers, and the COX inhibitor, indomethacin did not
significantly affect vascular relaxation induced by HCQ.
Conclusion: HCQ produced relaxation of RA rings. The relaxation mechanism differs according to the concentration of HCQ. At concentrations of 10-6 and 10-5 M, the relaxation is endothelium-dependent and mediated by NO. We strongly suggest that Ca2+ channel
inhibition is involved at concentrations of 10-5 and 10-4 M, as well as NO.
Key words: Hydroxychloroquine, nitric oxide, calcium channels, vasodilation

1. Introduction
Hydroxychloroquine (HCQ), a 4-aminoquinoline-type
antimalarial drug, was first introduced into the market
in 1955 several years after chloroquine (CQ), another
4-aminoquinoline-type antimalarial drug that differs from
HCQ by a missing hydroxyl group at the diethylamino
terminal, was taken into the clinical practice in 1947 [1].
Both HCQ and CQ had been alternatively developed as
safer antimalarial drugs in attempts to replace quinaqrine
which has a lower therapeutic index when applied in the
treatment of malaria. Discovery of the ameliorative effects
of quinacrine on cutaneous lupus and inflammatory
arthritis has initiated intensive research on HCQ and

CQ whose antiinflammatory results were published in
the early 1950s [2] leading to their medical applications
in the treatment of rheumatoid arthritis, systemic lupus
erythematosus (SLE), and other autoimmune diseases
[3]. Besides its antiinflammatory activity, HCQ has been
shown to take effect on various body systems [4].
Some cardiac adverse effects, mainly QT interval
prolongation and cardiomyopathy, are observed in
patients receiving HCQ. Some researchers have discussed
beneficial effects of HCQ on the cardiovascular profile
of rheumatoid arthritis patients [5,6]. Bengtsson et al.
investigated microvascular responses in the skin in SLE
patients taking antimalarial drugs. Arthritis patients

* Correspondence: oarslan@ybu.edu.tr

848

This work is licensed under a Creative Commons Attribution 4.0 International License.

ARSLAN et al. / Turk J Med Sci
taking HCQ responded more strongly to the endotheliumindependent vasodilating effect of sodium nitroprusside as
compared to those not taking HCQ [7].
The endothelium layer of vasculature is primarily
involved in the regulation of vascular tone via the
syntheses and release of endothelium-derived relaxing
factors such as nitric oxide (NO) and endothelium-derived
contracting factors [8]. Abiose et al., who studied the
vasodilation effect of CQ on dorsal hand veins, suggested
that the venodilation effect of CQ is mediated by NO and
histamine release [9]. Adegunluye et al. partly related the
vasodilating effect of mefloquine on rat aortic rings to the
endothelium, which could have mediated the inhibition of
calcium influx from extracellular medium as suggested by
the authors [10]. Aziba et al. studied the effects of CQ on rat
thoracic aorta and suggested that the vasorelaxation caused
by CQ was neither mediated by hyperpolarization nor by
endothelium-derived relaxing factors nor via the cGMP
pathway. As a result, the authors reached a conclusion that
CQ may exert its vasodilating effect via regulatory proteins
involved in the modulation of the contractile system [11].
Potassium (K+) ion channel activity is another important
regulator of vascular tone. Five different types of K+
channels are expressed in the vasculature: big conductance
Ca+2-activated (BKCa), voltage-activate (KV), ATP-sensitive
(KATP), inward rectifier (Kir), and two-pore domain
(K2P) K+ channels. These channels undergo changes in
expression and/or activity during major vascular diseases
such as hypertension and atherosclerosis [12].
Gomez et al. reported that chronic hydroxychloroquine
treatment has decreased hypertension and improved
endothelial dysfunction in NZBWF1 lupus mice [13].
In this study, we aimed to address the mechanism of the
effects of HCQ on rat aorta via conducting competitive
binding studies on K+ and Ca+2 ion channels as well as
the enzymes COX and eNOS involved in regulating the
vascular tone.
2. Materials and methods
2.1. Animals
Female Wistar-Albino rats (16–20 weeks old, weighing
200–250 g) were housed under controlled conditions (12
h light, 12 h dark, temperature: 20–22 °C; relative air
humidity: 50 ± 5%) in laboratory animal production and
research center Adıyaman university, Adıyaman, Turkey.
Diet and drinking water were given ad libitum.
All animal procedures were performed with the approval
of the Adıyaman University Animal Care and User
Committee (approval number: 19, accredited on June
25th, 2020) in accordance with the User Guidelines for the
Laboratory Animal Production and Research Center at
Adıyaman University.

2.2. Preparation of aortic rings
Rats were anesthetized by intraperitoneal injection of
xylazine (10 mg/kg) and ketamine (90 mg/kg). The chest
of each rat was opened to reveal the aorta. The aorta
was carefully cut out and placed into Krebs-Henseleit
solution [containing NaCl (118 mM), NaHCO3 (25 mM),
D-Glucose (10 mM), KCl (4.7 mM), MgSO4.7H2O (1.2
mM), K2HPO4 (1.2 mM), and CaCl2 (2.5 mM)], from
which fat and connective tissues were cleaned off fat and
connective tissue. The aorta was then sliced into 3–5 mm
long ring segments. Rat aortic (RA) rings were mounted
on wire hooks in a 10-mL organ bath (COMMAT
LTD, Turkey) containing Krebs-Henseleit solution and
continuously bubbled with a mixture of 95% O2 (g) and 5%
CO2 (g). The organ bath was kept at 37 °C. A transducer
system equipped with the Biopac Student Lab 4.0 (Biopac
Systems, Inc., USA) program was used to record the
contraction/relaxation responses of the tissue rings to the
chemicals.
2.3. Setting basal tension
At the beginning of each experiment, 1.5 g of passive
resting tension was applied on the ring segments which
were allowed to equilibrate for 90 min. The KrebsHenseleit solution was replenished every 15 min during
the equilibrium period.
2.4. Testing viability of the vessels
After tension equilibration, the viability of the aortic ring
segments was tested by adding potassium chloride (KCl)
at a final concentration of 45 mM into the organ bath.
Vessels that contracted by at least 1 g of force were used in
the experiments.
2.5. Effects of HCQ on intact and denuded endothelium
To determine a possible role of endothelium in HCQmediated vascular relaxation, aortas taken from rats were
sliced into two 3–5 mm long ring segments. The endothelial
layer of one of the aortic ring segments was mechanically
disrupted by rubbing the vessel gently against a stainlesssteel wire. The vascular ring segments were then treated
with 1 μM of aqueous phenylephrine (PE) solution in the
organ bath. Once vessel contractions reached a plateau
phase, acetylcholine (ACh) was added to the organ bath
at a final concentration of 10–5 M. Aortic ring segments
that showed at least 30% relaxation were considered intact
endothelium. While those that failed to relax more than
10% were accepted as denuded endothelium. The aortic
ring segments were rinsed with Krebs-Henseleit solution
three times and left in the organ bath to rest for 30 min.
Then, the resting aortic ring segments were recontracted
by addition of PE (1 μM) into the organ bath, to allow
them to reach a plateau phase, followed by addition of the
increasing final concentrations of 10–6 M, 10–5 M, 10–4 M,
and 10–3 M HCQ, respectively. Vascular responses were
recorded at each increment of HCQ concentration.
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2.6. Effects of HCQ on KCl and PE contractions
In this part of the study, the inhibition of the contractive
effect of KCl and PE on the RA ring segments of HCQ
at different concentrations was analyzed. After the
equilibration period, different RA rings were incubated
with HCQ 10–6 M, 10–5 M, 10–4 M, or 10–3 M (one
concentration in each organ bath) for 20 min, then KCl
45 mM or PE 1 μM were added. The contractions were
recorded and compared with HCQ-free control group.
2.7. Effect of potassium or calcium channel inhibitors on
aortic vessel response to HCQ
Possible roles of K+ or Ca2+ ion channels in HCQ-mediated
vasorelaxation were determined using the RA ring
segments that equilibrated and passed the viability test.
The selected RA ring segments were separately incubated
for 20 min in a 1 mM solution of tetraethylammonium
(TEA), a BKCa and KV inhibitor, a 1 mM solution of
4-aminopyridine (4-AP), a KV inhibitor, a 30 μM solution
of barium chloride (BaCl2), an inward rectifier K+ channel
(KIR) inhibitor, a 10 μM solution of glibenclamide (GLY),
an ATP-sensitive K+ channel inhibitor and a 10 μM
solution of nilvadipine, a Ca2+ channel inhibitor. The RA
ring segments were then contracted in 1 μM solutions
of PE to reach a steady contraction phase. This followed
incremental additions of HCQ from the stock solution
into the organ baths to yield 10–6, 10–5, 10–4, and 10–3 Molar
concentrations of HCQ, allowing 20 min time intervals in
between the HCQ concentration increments for recording
vasorelaxation.
2.8. Role of endothelium in vasodilatory effect of HCQ
Here, effects of nitric oxide synthase (NOS) and
cyclooxygenase (COX) inhibitors on aortic responses to
HCQ were tested. RA ring segments that equilibrated and
passed the viability test were incubated separately. RA rings
were incubated with a 10 μM solution of indomethacin
(INDO), a cyclooxygenase (COX) inhibitor, or a 100 mM
solution of N(ω)-nitro-L-arginine methyl ester (L-NAME),
a nitric oxide synthase (NOS) inhibitor, for 30 minutes. As
a control, one RA ring segment was processed without
NOS or COX inhibitors. To contract the vessels, a certain
amount of a stock solution of PE was then added to give
rise to 1 μM PE concentration in the organ baths. After
the contractions reached a plateau phase, certain amounts
of HCQ (from a stock) solution were incrementally added
to the organ baths at certain 10-6 M, 10-5 M, 10-4 M, and 103
M, respectively, in the organ baths. Vascular tensions were
measured in between the time intervals of HCQ addition
(5 min after each addition of HCQ) and compared to the
control as percentage of maximum contraction.
2.9. Effect of HCQ on CaCl2 induced contractions
In order to determine the effect of HCQ on Ca2+ influx
into smooth muscle/endothelial cells via L-type calcium
1
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channels, CaCl2 concentration response curves (from 10
μM to 10 mM) versus aortic vessel tension were plotted
in absence and presence of HCQ as described previously
[14]. RA ring segments that equilibrated and passed the
viability test were washed out with Ca+2-free Krebs solution
for 3 times at 10-min intervals, followed by incubation in
45 mM KCl for 20 min in absence or presence of HCQ
at varying concentrations (10–6M, 10–5 M, 10–4 M, and 10–3
M). Finally, cumulative concentration-response curves
were constructed by adding CaCl2 (10 μM to 10 mM) to
organ baths.
2.10. Chemicals
HCQ was isolated and purified by ultrasonic extraction
out of HCQ tablets (Plaquenil® by SANOFI, Paris, France),
using CH3OH:H2O (50:50) solvent system. The extraction
solvent system was finally evaporated under vacuum
by a rotary evaporator to yield pure HCQ as off-white
powder. GLY, 4-AP, and TEA were purchased from Sigma
Chemical Co. (St. Louis, MO, USA). KCl was obtained
from Carlo Erba reagents S.A.S (France). Dimethyl
sulfoxide was purchased from ISOLAB (Wertheim,
Germany). Indomethacin was purchased from Deva
(Istanbul, Turkey). L-NAME was obtained from Cayman
chemical (Ann Arbor, MI, USA). BaCl2 was obtained from
ZAG chemicals (Istanbul, Turkey).
2.11. Statistical methods
Relaxation responses of RA ring segments to HCQ and
ratios of KCl-, PE-, and CaCl2-induced contractions were
expressed in percent values. SPSS 18.0 (SPSS Inc., Chicago,
IL, USA) was used for statistical analysis. GraphPad Prism
7.04 (GraphPad Software, San Diego, CA, USA) was used
for graphical presentations. All results are expressed in
mean ± standard error of the mean (SEM). The sample
size calculation was based on a preliminary study. The
appropriate sample size was found to be 6 using online
software (Experimental Design Assistant1; alpha=0.05,
power=85%). A standard effect size of 1 (medium effect)
was chosen based on Cohen’s d guidelines. Standard
deviation (SD) value was found to be 0.6. It was calculated
based on data from the preliminary study using SPSS
18.0. A one-sided test was performed. Data normality test
with Shapiro–Wilk found a value more than 0.05 so that
the data is said to be normally distributed. Furthermore,
the homogeneity test obtained a value more than 0.05;
accordingly, the research sample was confirmed to be
homogenous.
Statistical significance between 2 independent groups
was determined by independent sample t test. One-way
analysis of variance test (ANOVA) and Scheffe’s post
hoc test were used for comparing multiple groups. A
probability level of p < 0.05 was considered statistically
significant.
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3. Results
3.1. Response of intact and denuded endothelium to
HCQ
Initially, it is essential to address whether, contracted or
relaxed, the endothelial cells are involved in a response
given to HCQ administration.
The response of intact and denuded endothelium exposed
to HCQ was determined in presence of lower (10–6 to10–5
M) and higher (10–4 to 10–3 M) concentrations of HCQ.
It was determined that all concentrations of HCQ were
able to relax the intact endothelium of the precontracted
RA ring segments (Figure 1A), while the endotheliumdenuded precontracted RA ring segments exhibited
very little or virtually no relaxation (p < 0.001) at lower
HCQ concentrations (Figure 1B). Relaxation of the
denuded endothelium became more prominent, and yet
less than that of the intact endothelium, when higher
HCQ concentrations were used (Figure 2). HCQ was
not observed to influence resting RA ring segments. The
results were statistically significant (p < 0.01).
3.2. Effect of HCQ on vascular contractions induced by
PE, KCl, and CaCl2
Having found that HCQ induces aortic vasodilation, the
effect of HCQ was further tested on RA ring segments
precontracted by PE, an α1-adrenergic receptor agonist,
KCl, and CaCl2.
Addition of suitable amounts of PE or KCl from their
stock solutions to yield final concentrations of 10–6 M or 45
mM, respectively, in organ baths resulted in significantly
less contractions (see Figures 3 and 4) when RA ring
segments were incubated in 10–4 M HCQ, with p < 0.01
and p < 0.05 values for the PE (Figure 3) and KCl (Figure
4) groups, respectively, as determined in reference to the
control and 10–3 M HCQ, with p < 0.001 and p < 0.01
values for the PE (Figure 3) and KCl (Figure 4) groups,
respectively, as determined in reference to the control,
where the control group included no HCQ.
Figure 5 exhibits plots of percent CaCl2 induced
contractions of RA ring segments versus increasing
concentrations of CaCl2 (10–5–10–2 M), all incubated
separately in different concentrations of HCQ solution
(10–6–10–3 M). As far as Ca2+-induced aortic contractions
are concerned, the relaxation property of HCQ takes more
prominent effect at relatively higher concentrations of
HCQ, specifically at 10–4 M (with p < 0.05, p < 0.01, p <
0.01, and p < 0.001 values, respectively, for the RA ring
segments pre-contracted in 10–5 M, 10–4 M, 10–3 M, and
10–2 M Ca2+ solutions respectively) and 10–3 M (with p <
0.05, p < 0.01, p < 0.001, and p < 0.001 values, respectively,
for the RA ring segments precontracted in 10–5 M, 10–4 M,
10–3 M, and 10–2 M Ca2+ solutions, respectively) (Figure 5),
as compared to the control group in which no HCQ was
used.

3.3. Effects of inhibitors of NOS, COX, calcium channels,
and potassium channels on HCQ-induced vascular
relaxation
Whether K+ channels, Ca2+ channels, COX, or NOS have
any role in the mechanism of HCQ-induced relaxation
was investigated by using their inhibitors. Blocking the
four K+ channels, namely: BKCa, KV, KATP and KIR, has no
effect on the relaxation obtained with HCQ. Similarly,
incubating RA rings with the COX inhibitor indomethacin
has failed to show statistically significant differences in
HCQ-induced relaxation. However, as shown in Figure
6, the inhibition of NOS by incubating RA rings with
L-NAME resulted in less vascular relaxation in response to
HCQ, which was statistically significant compared to the
control group at HCQ concentrations; 10–6 M (p < 0.001),
10–5 M (p < 0.001), 10–4 M (p < 0.01), and 10–3 (p < 0.05).
Nilvadipine incubation relaxed both endothelium-intact
and -denuded rings; and the relaxation of -denuded rings
was lower compared to the control group (p < 0.01 for 10–6
and 10–5 M, and p < 0.05 for 10–4 and 10–3 M) (Figure 7).
4. Discussion
Chloroquine and hydroxychloroquine are antimalarial
drugs that are also commonly prescribed for rheumatoid
arthritis, SLE, and other autoimmune diseases. Regarding
their effects on vascular smooth muscle, CQ had taken
the bigger share of research, whereas HCQ was not
investigated that much; possibly because the former was
more widely used in the clinical setting. Capel et al. studied
the in vitro effect of cumulative doses of HCQ (1–10 μM)
on spontaneous beating rate in mouse atrial preparations.
However, the vascular effects of HCQ have not been studied
[15]. In this study, we found that HCQ relaxes RA rings
precontracted with phenylephrine in a concentrationdependent manner. To find out the mechanism underlying
this relaxing effect, we made a series of experiments on
endothelium-denuded and endothelium-intact rings,
and used blockers of K+ channels, Ca2+ channels, and
inhibitors of COX and eNOS enzymes. Our laboratory
results indicate that HCQ induces vasodilation partly via
endothelium and partly due to endothelium-independent
mechanisms.
The endothelium layer of blood vessels is an extremely
important element in vascular dilation used both by
endogenous substances, e.g., acetylcholine, substance P,
ATP, bradykinin [16], and exogenous compounds [17,18].
Our results show a considerable role of the endothelium
in mediating HCQ-induced relaxation, exhibited by
less relaxation of the RA rings in response to HCQ at
the tested concentrations, 10–6 M–10–3 M, when the
endothelium is removed. Adegunloye et al. studied the
effects of mefloquine—another congener of HCQ—on
rat aortic rings and suggested that mefloquine-induced
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Figure 1. Continuous transducer recording for HCQ (10–6 M, 10–5 M, 10–4 M, and 10–3M)-induced relaxations of (A) intact and (B)
denuded endothelium of RA ring segments, which were precontracted via PE (10–6 M).

Figure 2. Plots of percent vascular relaxation versus hydroxychloroquine concentrations (10–6 M,
10–5 M, 10–4 M, 10–3 M) applied on denuded and intact endothelium of RA ring segments previously
precontracted with 10–6 M of phenylephrine solution in the organ bath. Values are expressed in mean ±
SEM (n = 7). *** and ** denotes p < 0.001 and ** p < 0.01, respectively.

relaxation is partly endothelium-dependent [10]. Aziba
et al., who studied the effect of chloroquine on RA rings,
stated that vascular relaxation obtained by chloroquine
was endothelium-independent. Nevertheless, they
denoted that uncovering detailed mechanism of
relaxation needs more research [11]. Since the
endothelium contributes to vascular relaxation through
many factors, we went forward to determine which one
is the main player. While relaxation of RA rings by HCQ
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was not affected by incubation with the COX inhibitor,
indomethacin, our results show appreciable reduction in
HCQ-induced relaxation in RA rings incubated with the
eNOS inhibitor, L-NAME. In addition, the mechanical
denudating of endothelium significantly reduced the
relaxation. These results indicate that stimulation of NO
production, which relaxes smooth muscle by increasing
cyclic GMP levels, and of eNOS is associated with the
relaxation in RA rings.

ARSLAN et al. / Turk J Med Sci

Figure 3. Percent phenylephrine (PE, 10-3 M)-induced contraction
of RA ring segments incubated at increasing concentrations of
hydroxychloroquine (HCQ, 10–6–10–3 M). Percent contraction
values are given in mean ± SEM (n = 6). *** denotes p < 0.001
and ** indicates p < 0.01 as compared to the control group.

Figure 4. Percent potassium chloride (KCl, 10-3 M)-induced
contraction of RA ring segments incubated at increasing
concentrations of hydroxychloroquine (HCQ, 10–6–10–3 M).
Percent contraction values are given in mean ± SEM (n = 6). **
denotes p < 0.01 and ** indicates p < 0.05 as compared to the
control group.

The venodilating effect of chloroquine on human
hand veins was mediated by the endothelium as shown by
Abiose et al. Further inhibition of chloroquine-produced
relaxation by coinfusion of H1/H2-receptor antagonist
and NOS antagonist made the researchers suggest that
chloroquine may partly act by stimulating histamine
release [9]. Chloroquine was also shown by Ghigo et al.
to stimulate NOS activity in murine, porcine, and human

endothelial cells [19]. In one study, the effect of HCQ on
vascular reactivity in systemic lupus erythematosus (SLE)
mouse model was investigated. It was found that HCQ
was able to restore vascular response to acetylcholine by
increasing NO production, an effect that was abolished
by L-NAME [13]. In a study examining the effects of
chloroquine on the coronary artery of control and diabetic

Figure 5. Percent calcium chloride (CaCl2, 10–5–10–2 M)-induced contraction of RA ring segments
incubated at increasing concentrations of hydroxychloroquine (HCQ, 10–6–10–3 M). Percent
contraction values are given in mean ± SEM (n = 6). * is p < 0.05 at 10–4 M CaCl2, ** is p < 0.01 at
10–4–10–3 M CaCl2, and *** is p < 0.001 at 10–2 M CaCl2 as compared to the control group. # p < 0.05,
##
p < 0.01, and ###p < 0.001 for HCQ 10–3 M vs. control group.
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Figure 6. Relaxation of RA rings in response to hydroxychloroquine (10–6–10–3M) after incubation with K+ channel
blockers: TEA, 4-AP, GLY, BaCl2, the COX enzyme inhibitor indomethacin or the endothelial NOS inhibitor L-NAME.
Values are expressed as mean ± SEM (n = 7). ***p < 0.001 and *p < 0.05 vs. control group.

Figure 7. Relaxation of RA rings in response to hydroxychloroquine (10-6 M–10-3M) after incubation
with Ca2+ channel blocker, nilvadipine (10 μM). Values are expressed as mean ± SEM (n = 6). **p <
0.01 and *p < 0.05 for endothelium-denuded group vs. control group.

mice, the researchers found that chloroquine increased
endothelium-dependent relaxation of the diabetic coronary
arteries by enhancing EDHF pathway [20]. However, we
found that indomethacin did not change the HCQ-induced
relaxation of endothelium-intact RA rings, confirming that
such relaxation may not be induced by prostaglandins or
by concomitant production of prostacyclin.
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Interestingly, only modest vasodilation effect of HCQ
was observed in lower concentrations of HCQ solutions
such as 10–6 M and 10–5 M, as relaxation of HCQ was
little inhibited at 10–5 M and 10–6 M concentrations in the
endothelium-denuded and L-NAME incubated RA rings.
We are suggesting that HCQ may not directly exert
its effect on Ca2+channels to inhibit Ca2+ influx both in

ARSLAN et al. / Turk J Med Sci
endothelial and smooth muscle cells. Rather, it is highly
likely that HCQ may trigger an external pathway that
indirectly signals the Ca2+ ion channels to stop Ca2+
influx and it would take greater concentrations of HCQ
for trafficking the signal to the Ca2+ ion channels. Several
investigators have highlighted the principal role of
Ca2+ channels in bringing about vascular relaxation by
chloroquine. Wu et al. concluded that chloroquine blocks
store-operated, receptor-operated, and voltage-operated
Ca2+ channels in pulmonary artery smooth muscle cells
[21]. HCQ has been described by Capel et al. to inhibit
multiple ion channels in sinoatrial node, including: funny
current, rapid delayed rectifier potassium current, and
L-type Ca2+ ion current leading to a significant reduction
in spontaneous action potential firing rate [15]. In the
present study, contractile responses to Ca2+ of RA rings
exposed to KCl was used to identify agents which possess
Ca2+ channel antagonist actions. The reason is that KCl
depolarizes cell membranes and opens voltage-gated Ca2+
channels to permit extracellular Ca2+ to enter the cytosol
and produce contractions [22]. To explore the involvement
of Ca2+ channels in HCQ-produced vascular relaxation, we
suspended RA rings in Ca2+-free Krebs solution, incubated
HCQ in four different concentrations (10–6–10–3 M), then
added CaCl2 (10–5–10–2) in a cumulative manner. We
observed that the higher the incubated HCQ concentration
is, the lower the contraction induced by CaCl2 is. In
addition, after incubation of nilvadipine blocking L-type
Ca2+ channels in vascular muscle cells [23], HCQ produced
relaxation like the control group in RA rings precontracted
with PE. This is in concordance with a previous study that
demonstrated that chloroquine induces vasodilation in
rat aorta at high concentration (>10–4 M) via inhibiting
voltage‐dependent L‐type Ca2+ channel [24]. Our results
suggested that HCQ can also produce vascular relaxation
by blocking Ca2+ channels and preventing Ca2+ influx in
both endothelium-denuded and -intact RA. The relaxation
mediated by the Ca2+ channels was observed to be more
evident at 10–4 M and 10–3 M HCQ concentrations that are
unattainable at clinical blood concentrations [25].
Five types of K+ channels are present in vascular
smooth muscles, and they play a crucial role in regulating
vascular tone. Activation of K+ channels is a key
mechanism of vasorelaxation caused by many drugs [26],
such as sirolimus, levosimendan, pinacidil and propofol
[26–29]. The activation of K+ channels lead to K+ efflux,
membrane hyperpolarization and subsequent vascular
relaxation [12]. BKCa plays an important role in regulating
vascular tone, especially in conduit arteries. The relaxation
induced by BKCa activation of some drugs in the vascular
smooth muscles has been demonstrated such as propofol-

internal mammary artery [26] and -rat aorta [14], and
levosimendan-umbilical artery [30]. To illuminate the
possible roles of K+ channels in relaxation of pulmonary
artery produced by chloroquine, Wu et al. used blockers
of BKCa and KV channels, and stated that their effects
were unnoticeable [21]. Whether or not HCQ activates
K+ channels in RA rings has not been studied as far as
we know. Accordingly, we incubated RA rings in Krebs
solution containing blockers of BKCa, KATP, KV, and KIR
channels. RA rings were precontracted by the addition of
PE, then HCQ (10–6–10–3 M) was added in a cumulative
manner. HCQ produced vascular relaxation comparable
to that obtained in the control RA rings. Thus, we could
not find any significant association between K+ channels
and vascular relaxation.
Pestana et al. reached a conclusion that inhibition
of autophagy by chloroquine had restored NO levels
on human umbilical vascular endothelial cells. They
also found that incubating RA rings with chloroquine
had resulted in endothelium-dependent relaxation in
which the contribution of increased NO synthesis was
confirmed [31]. Like chloroquine, HCQ is also known
to be an inhibitor of autophagy by interference with
lysosomal activity [3]. Transient receptor potential (TRP)
channels are superfamily of cation channels; and, almost
all functionally characterized transient receptor potential
(TRP) channels are Ca2+ permeable, although not selective
for Ca2+. TRPV4 (a member of the vanilloid subfamily of
TRP channels) has been detected in both vascular smooth
muscles and endothelial cells of rat cerebral artery and aorta
[32]. Zhang et al. emphasized the importance of TRPV4
in mediating agonist-induced vascular dilation through
endothelial-derived hyperpolarizing factors (EDHF) [33].
Whether inhibition of autophagy and TRPV4 activation
by HCQ could contribute to the vascular relaxation was
not examined in our study. Activation of TRPV4-EDHF
and inhibition of autophagy are other possible relaxation
pathways worthy to be investigated.
In summary, vascular smooth muscles can be
relaxed by endothelium-dependent and endotheliumindependent mechanisms. The present study shows that
the relaxation of RA rings by HCQ is partly through NO
and associated with blocking voltage gated Ca2+ channels.
K+ channels have been shown to have no role in mediating
relaxation. The observations from this study indicate that
HCQ may be used in patients with noncardiac disease due
to an ameliorative effect of HCQ on vascular diseases such
as hypertension that causes vascular dysfunction.
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